Roche has launched a CE certified IVD version of the MagNA Pure 96 System for automated sample preparation.
By providing lot-to-lot consistency and high quality, the Swiss pharmaceutical firm says the new MagNA Pure 96 System will meet the needs of customers better. The IVD version of MagNA Pure 96 was introduced in the US in 2011.
The MagNA Pure 96 System is able to purify a broad spectrum of human samples and offers LIMS (laboratory information management system) connectivity for safer and more convenient data transfer, says Roche. It provides ready-to-use reagents and uses a minimal number of consumables for purification of nucleic acids from up to 96 clinical samples in less than one hour. The instrument performance characteristics of MagNA Pure have been established in external trials with model parameters.
‘The proven robustness and unmatched speed of the MagNA Pure 96 System are now available in a CE-marked IVD solution and make the instrument suitable for diagnostic applications in clinical labs around the world,’ said Gerd Haberhausen, business head of qPCR and Nucleic Acid Purification.
‘This is an important fact for Clinical Research Organisations that operate globally and who need to ensure that clinical trials are based on tools providing consistent quality as well as for global institutions conducting medical research and molecular diagnostic testing.’
